Related Experiment Videos
Humoral response in patients with chronic heart failure
L Spinarová1, J Toman, J Pospísilová
11st Internal Department, Masaryk University, Brno, Czech Republic.
International Journal of Cardiology
|September 18, 1998
Summary
Big endothelin and endothelin-1 levels correlate with key indicators of chronic heart failure severity. This finding aids in understanding and evaluating heart failure progression using these biomarkers.
Area of Science:
- Cardiology
- Biomarkers
- Heart Failure Research
Background:
- Chronic heart failure (CHF) management requires accurate assessment of disease severity.
- Humoral markers offer potential non-invasive indicators of cardiac function.
Purpose of the Study:
- To investigate the correlation between five humoral markers and various clinical, echocardiographic, and hemodynamic parameters in CHF patients.
- To identify potential biomarkers for assessing the severity of chronic heart failure.
Main Methods:
- Studied 29 patients with CHF (NYHA II-III, EF < 40%).
- Assessed levels of thromboxane, prostaglandin F, tumor necrosis factor-alpha, endothelin-1, and big endothelin.
- Correlated these markers with laboratory tests, chest X-ray (cardiothoracic index), right heart catheterization (pulmonary artery pressure, wedge pressure, vascular resistance), and echocardiography (volumes, ejection fraction, mitral inflow).
Main Results:
- Thromboxane, prostaglandin F, and TNF-alpha showed no significant correlation with assessed parameters.
- Endothelin-1 correlated with mitral E/A, pulmonary vascular resistance, and mean pulmonary artery pressure.
- Big endothelin demonstrated significant correlations with end-diastolic volume, end-systolic volume, pulmonary artery pressure, wedge pressure, and systemic vascular resistance.
Conclusions:
- Big endothelin levels strongly correlate with key hemodynamic and imaging parameters of heart failure severity.
- Endothelin-1 also shows a notable correlation with specific heart failure indicators.
- These findings suggest big endothelin and endothelin-1 as valuable biomarkers for evaluating chronic heart failure.